Maryam Y,Richard CB.Coagularion and fibrinolytic protein kinetics in cardio-pulmonary bypass [J]. J Thromb Thrombolysis,2009,27:95-104.
[2]
Ribo M,Montaner J,Monasterio J,et al.Role of homocysteine in the acute phase of stroke [J].Neurologia,2004,19:10-14.
[3]
Santos AT,Splettstosser JC,Warpechowski P,et al.Antifibrin-olytics and cardiac surgery with cardiopulmonary bypass [J].Rev Bras Anestesiol,2007,57:549-564.
[4]
Yavari M,Becker RC.Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass [J].J Thromb Thrombolysis,2009,27(1):95-104.
[5]
Mannucci PM,Levi M.Prevention and treatment of major blood loss[J].N Engl J Med,2007,31,356(22):2301-2311.
Stefanidis A,Skafidas D,Papasteriadis E. Discrepancy in guidelines for the prevention of thrombo-embolism inpatients with prosthetic heart valves[J].Eur Heart J,2007,28(20):2252-2553.
[9]
Du L,Gao ZG,Nithipatikom K,et al.Protection from myocardial ischemia /reperfusion injury by a positive allosteric modulator of the A(3)adenosine receptor[J].J Pharmacol Exp Ther,2012,340(1):210-217.
